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Background: The numbers of people requiring total arthroplasty is expected to increase substantially over the next
two decades. However, increasing costs and new payment models in the USA have created a sustainability gap. Ad
hoc interventions have reported marginal cost reduction, but it has become clear that sustainability lies only in
complete restructuring of care delivery. The Perioperative Surgical Home (PSH) model, a patient-centered and
physician-led multidisciplinary system of coordinated care, was implemented at UC Irvine Health in 2012 for patients
undergoing primary elective total knee arthroplasty (TKA) or total hip arthroplasty (THA). This observational study
examines the costs associated with this initiative.
Methods: The direct cost of materials and services (excluding professional fees and implants) for a random
index sample following the Total Joint-PSH pathway was used to calculate per diem cost. Cost of orthopedic implants
was calculated based on audit-verified direct cost data. Operating room and post-anesthesia care unit time-based costs
were calculated for each case and analyzed for variation. Benchmark cost data were obtained from literature search. Data
are presented as mean ± SD (coefficient of variation) where possible.
Results: Total per diem cost was $10,042 ± 1,305 (13%) for TKA and $9,952 ± 1,294 (13%) for THA. Literature-reported
benchmark per diem cost was $17,588 for TKA and $16,267 for THA. Implant cost was $7,482 ± 4,050 (54%) for TKA and
$9869 ± 1,549 (16%) for THA. Total hospital cost was $17,894 ± 4,270 (24%) for TKA and $20,281 ± 2,057 (10%) for THA.
In-room to incision time cost was $1,263 ± 100 (8%) for TKA and $1,341 ± 145 (11%) for THA. Surgery time cost was
$1,558 ± 290 (19%) for TKA and $1,930 ± 374 (19%) for THA. Post-anesthesia care unit time cost was $507 ± 187 (36%) for
TKA and $557 ± 302 (54%) for THA.
Conclusions: Direct hospital costs were driven substantially below USA benchmark levels using the Total
Joint-PSH pathway. The incremental benefit of each step in the coordinated care pathway is manifested as a
lower average length of stay. We identified excessive variation in the cost of implants and post-anesthesia care.
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Total knee arthroplasty (TKA) and total hip arthroplasty
(THA) show high cost–utility, cost-effectiveness, and
cost–benefit over other interventions [1-3]. However,
the cost of care delivery in the USA has increased to the
point that total arthroplasty (TA) is now the largest ex-
penditure per procedure in Centers for Medicare and* Correspondence: raphaeld@uci.edu
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Coupled with declining reimbursement, hospitals have
struggled to maintain profitability for these procedures.
The passage of the Affordable Care Act and implementa-
tion of performance-based bundled payments threatens to
exacerbate this sustainability gap if significant cost-control
measures are not implemented. Furthermore, as the ‘baby
boomer’ generation ages and obesity continues to rise in
the general population, the demand for primary TKA and
THA in the USA is expected to increase substantially over
the next two decades [5,6].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Components of per diem cost
Time-based Non time-based
Operating room time Equipment





Table 2 Demographics of the included patientsa
TKA (n = 129) THA (n = 77)
Age 65 ± 10.53 64 ± 13.82
BMI 30.7 ± 5.7 28.5 ± 7.2
Spinal anesthesia 61% 57%






ASA, American Society of Anesthesiologists Physical Status; BMI, body mass
index; THA, total hip arthroplasty; TKA, total knee arthroplasty.
aData are expressed as mean ± SD.
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tial hospital stay are mostly driven by three major fac-
tors: implant cost, hospital length of stay (LOS), and
operating room (OR) cost [4,7-9]. Implant cost has in-
creased sharply over the past two decades, with many
new and more complex options brought to market. Im-
plant cost minimization strategies may be found in the
literature, including implant standardization, group pur-
chasing, gain sharing, price ceilings, and the creation of
a national joint database to track outcomes and inform
purchasing decisions. LOS reduction efforts have exam-
ined modern surgical techniques and multimodal pain
management, and described post-operative clinical path-
ways that employ early mobilization and rehabilitation
as well as reduction of post-operative complications. OR
cost reduction has focused mainly on surgical techniques
and operational efficiency. These ad hoc interventions
have been shown to reduce costs marginally in USA
hospitals, but none has addressed the broader issue of a
fragmented and inefficient perioperative system. The
transition to performance-based bundled payments in
the USA has illustrated the need for the adoption of
perioperative practice models similar to those that have
been in place in Europe for over a decade with proven fi-
nancial benefits.
We submit that sustainable cost reduction lies only in
a complete restructuring of how TA care is delivered.
The Perioperative Surgical Home (PSH) is a recently
proposed perioperative practice model in the USA. The
goal of the PSH is to improve clinical outcomes while
providing better perioperative service to patients at
lower cost [10,11]. This model has been described as a
‘patient-centered and physician-led multidisciplinary and
team-based system of coordinated care that guides the
patient throughout the entire surgical experience.’ The
first PSH program was implemented at UC Irvine Health
in 2012 for all elective TKA and THA [12,13]. The in-
tent of the program is to support the orthopedic sur-
geon, ensure adherence to mutually agreed-upon protocols,
and manage medical issues that arise during the episode of
care. The surgeon’s role as ultimate decision-maker is main-
tained. A major aim of the Total Joint-PSH protocol is to re-
duce variation in care delivery, which will in turn reduce
cost and improve outcomes [4,12-15]. This observational
study examines the cost and cost variation associated with
the Total Joint-PSH, and compares to reported benchmarks.
Methods
We performed an observational cost analysis for patients
undergoing primary unilateral elective THA or TKA
under the Total Joint-PSH model at UC Irvine Health
between October 1, 2012 and September 30, 2013. Insti-
tutional review board approval was obtained with the pur-
pose of analyzing and reporting our results, and patientconsent was waived (IRB HS#2012-9273). The implemen-
tation of the Total Joint-PSH program at our institution
has been described in detail elsewhere [12,13].
Implementing the Total Joint-PSH program
The Total Joint-PSH program was created prior to rees-
tablishment of an arthroplasty center at UC Irvine
Health in 2012. The lack of an existing program allowed
all stakeholders (including orthopedic surgeons, anesthe-
siologists, acute pain physicians, nurses, rehabilitation
specialists, and hospital administrators) to have a voice
in its design and implementation. All team members
were trained in Lean Six Sigma (LSS), and agreed to ad-
here to the concepts of standardization and reduced
variability. The goal of this process was to integrate four
distinct perioperative phases: pre-operative, intra-operative,
post-operative and post-discharge. A value stream map
(flow diagram documenting in high detail every step of the
process) was created for each perioperative phase. The pre-
operative process incorporates expectation management,
early discharge planning, protocol-driven health risk
assessment, and medical optimization. Standardized
anesthetic, nursing, and surgical care protocols, as well
as Goal Directed Fluid Therapy (GDFT) underpin the
intra-operative component. Post-operative management
provides for multimodal analgesia, a targeted recovery
plan, early ambulation, nutrition management, and prompt
rescue from complications. Post-discharge care begins in
Table 3 Summary of costsa
Costs TKA THA
Per diem cost
(LOS = 3 days)
$10,042 ± 1305 (13%) $9,952 ± 1294 (13%)
Orthopedic materials
and implants
$7,482 ± 4050 (54%) $9,869 ± 1549 (16%)
Total cost $17,524 ± 4255 (24%) $19,821 ± 2018 (10%)
LOS, length of stay; THA, total hip arthroplasty; TKA, total knee arthroplasty.
aData are expressed as mean ± SD (coefficient of variation).
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rehabilitation setting. Once the perioperative pathways
were fully vetted, the Total Joint-PSH program was offi-
cially launched on October 1, 2012.
Cost analysis
Per diem cost analysis
The direct cost of materials and services (excluding pro-
fessional fees and implants) provided during each hos-
pital day of care were obtained from the UC Irvine
Health financial decision support office. Data were pro-
vided for a randomly chosen index sample (n = 29 or
14%) of patients who had undergone unilateral primary
arthroplasty following the Total Joint-PSH pathway. Data
from this sample were used to determine average per
diem cost for each day of admission. Components of per
diem cost are presented in Table 1. Per diem cost for
post-operative day (POD) 0 included costs incurred dur-
ing pre-operative health risk assessment and optimization
in the operating room (OR) and in the post-anesthesia
care unit (PACU). The cost of pre-operative orthopedic
clinic professional visits was not included. Costs incurred
during POD 1 to 3 included room and board as well as all
activities related to recovery and discharge planning. The
previously reported average LOS for the Total Joint-PSH
was 2.7 ± 0.64 days for TKA and 2.6 ± 0.67 for THA [12],
thus a conservative value of 3 days LOS was used to calcu-
late total per diem cost.Figure 1 Implants cost. (A) total knee arthroplasty; (B) total hip arthroplaSpecialized orthopedic materials and implant cost analysis
All specialized orthopedic materials and implants used
in the OR were recorded by nursing staff intra-operatively,
and verified by the revenue audit department. Data from
all patients (n = 206) undergoing elective primary unilateral
TKA and THA were used to examine the cost of ortho-
pedic materials and implants. The average cost of ortho-
pedic materials and implants was calculated using the
acquisition cost.
Total cost analysis
Total cost for primary TKA and THA performed as part
of the Total Joint-PSH program was calculated as the
sum of the total per diem cost, orthopedic materials
cost, and implant cost. Total cost for was calculated for
all cases.
Determination of OR and PACU cost per minute
The cost of OR time was calculated in the following
manner. Aggregate direct cost data for the index patient
sample was obtained from the decision support office.
OR-related costs (excluding implants) were identified.
Materials typically used during the first 30 minutes of
OR time were also identified. Two average total costs
were calculated, one for the first 30 minutes and one for
costs incurred thereafter. Total OR time was obtained
by database query of the intra-operative electronic med-
ical record (EMR) (Surgical Information Systems, LLC,
Alpharetta, GA, USA). Using these data, a cost per mi-
nute was calculated for the first 30 minutes and for sub-
sequent OR time. An analogous process was performed
to obtain cost per minute values for PACU time.
OR and PACU time variation and cost analysis
Total OR and PACU times were determined by database
query of the intra-operative and post-operative EMR for
all patients undergoing elective unilateral primary TKA
and THA. In-room to incision time and surgical timesty.
Table 4 Summary of OR time costsa
TKA THA
In-room to incision time cost $1,263 ± 100 (8%) $1,341 ± 145 (11%)
Surgery time cost $1,558 ± 290 (19%) $1,930 ± 374 (19%)
PACU time cost $507 ± 187 (36%) $557 ± 302 (54%)
Total OR & PACU time cost $3,329 ± 350 (11%) $3,828 ± 559 (16%)
OR, operating room; PACU, post-anesthesia care unit; THA, total hip arthro-
plasty; TKA, total knee arthroplasty.
aData are expressed as mean ± SD (coefficient of variation).
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values, a time-based cost was determined for the compo-
nents of each case.Data analysis
Variation in cost was assessed using coefficient of variation
(defined as SD/mean). Data are presented as mean ± SD
(coefficient of variation). All statistics were performed
using SPSS software version 11.0 (SPSS Inc., Chicago, IL,
USA).Results
In total, 206 (n = 129 for TKA and n = 77 for THA) se-
quential patients undergoing unilateral primary TA wereFigure 2 Surgical time cost for total knee arthroplasty. (A) In-room to
(PACU) time cost; and (D) total operating room (OR) and PACU time cost.enrolled in the Total Joint-PSH protocol. Demographics
are presented in Table 2.
Total cost analysis
A summary of costs (per diem cost, orthopedic materials
and implants cost, and total calculated cost) is presented
in Table 3. Individual cost of implants for all cases is
presented in Figure 1.
Time-based cost analysis
A summary of OR time costs is presented in Table 4. In-
dividual case costs (in-room to incision time cost, sur-
gery time cost, PACU time cost, and total OR and
PACU time cost) for TKA and THA are presented in
Figure 2 and Figure 3, respectively.
Discussion
Our analysis shows a low total cost for unilateral pri-
mary TKA and THA in the setting of the first Total
Joint-PSH. Prior to implementation of the Total Joint-
PSH program, our institution had no active arthroplasty
program. This study is observational in nature, and no
comparison with prior costs was made. We sought in-
stead to benchmark our cost data against figures re-
ported in the literature. A recent retrospective study ofincision time cost; (B) surgery time cost; (C) post-anesthesia care unit
Figure 3 Surgical time cost for total hip arthroplasty. (A) In-room to incision time cost; (B) surgery time cost; (C) post-anesthesia care unit
(PACU) time cost; (D) total operating room (OR) and PACU time cost.
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hospital cost (episode cost excluding implants) of
$17,588 for TKA and $16,267 for THA. Hospital episode
cost for the Total Joint-PSH patient at our institution
($10,042 ± 1305 for TKA and $9,952 ± 1294 for THA)
was found to be significantly below this benchmark
(Table 5). The reduced LOS in our institution (4 versus
3 days) is a major factor in this comparative cost reduc-
tion. We contend that the incremental benefit of each
step in the Total Joint-PSH coordinated care pathway is
manifested as a low average LOS (rapid recovery). Cost
savings attributed to reduced LOS must be considered
in the context of equivalent outcomes, as complications
can contribute substantially to the overall cost of arthro-
plasty. We have previously reported low complication
and re-admission rates for patients in the Total Joint-Table 5 Benchmark cost comparison: average hospital
cost excluding implantsa
Total Joint-PSH Benchmark [16]
TKA $10,042 ± 1,305 $17,588
THA $9952 ± 1,294 $16,267
PSH, perioperative surgical home; THA, total hip arthroplasty; TKA, total
knee arthroplasty.
aData are expressed as mean ± SD.PSH compared with published data [12], but the contri-
bution of complications to overall cost of care was not
considered in this analysis.
The second largest cost driver was identified as cost of
implants $7,482 ± 4,050 (TKA) and $9,869 ± 1,549 (THA).
Implant cost was recently examined in the literature, and
found to range from $1,797 to $12,093 (TKA) and $2,392
to $12,361 (THA) [9]. Implant cost at our institution was
within this benchmark range. However, the cost of im-
plants was the largest source of cost variation in the Total
Joint-PSH, at 54% (TKA) and 16% (THA). Variation in
implant cost is appropriate as a reflection of patient demo-
graphics and underlying conditions, particularly in the set-
ting of a tertiary care academic center. However, a
component of this variation can be attributed to other fac-
tors. UC Irvine Health is currently engaged in an initiative
to reduce implant cost variability and overall implant cost.
Operating room and PACU cost was determined using
a time-based cost analysis. It has been argued that re-
duction in OR time does not result in cost savings unless
enough time is saved to add an additional case during
regular operating hours. This reasoning presumes all OR
costs are fixed; however, a number of OR resources
(such as staffing) are variable direct costs that can be
reallocated if OR time is reduced. Determination of the
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savings and illustrate the importance of operational effi-
ciency. We examined variation in terms of cost rather
than time because our model assigns a higher cost to
the initial 30 minutes of OR and PACU times. In our
analysis, variation in OR time cost for the Total Joint-
PSH was found to be low. Cost associated with in-room
to incision time varied by 8% (TKA) and 11% (THA).
We attribute this low variation to a well-defined, time-
limited decision tree for conversion of difficult neuraxial
to general anesthesia. Cost associated with surgery time
varied by 19% (TKA and THA). Relatively low variation
in these parameters enables predictable optimization of
OR scheduling. Excessive variation of 36% (TKA) and
54% (THA) was found in the PACU time cost analysis.
The data showed several outliers, which upon initial in-
vestigation were attributable to limited availability of
beds in the orthopedic ward at the desired time of
PACU discharge. This finding has alerted the Total
Joint-PSH team to the need for further study and an LSS
analysis of this process step.
Minimizing direct hospital costs without improvement
in care or outcomes may simply shift cost to the post-
discharge arena. The cost of orthopedic rehabilitation
hospital care, home-based care, emergency room visits,
complications, and readmissions must be closely tracked.
A recent study of TJA costs found that post-discharge
payments accounted for an average of 36% of total epi-
sode of care payments [16]. The current observational
cost analysis of the Total Joint-PSH cohort did not con-
sider post-discharge care, and some component of cost
shifting may exist. We recognize this as a challenging
and pressing area of future study.
The PSH is a care delivery model that has been en-
dorsed by the American Society of Anesthesiologists
(ASA), with the goal of improving clinical outcomes
while providing better perioperative service at lower
cost. Future studies will be geared toward comparing the
PSH with other models of care.
Conclusions
We found that direct hospital costs can be driven sub-
stantially below benchmark levels using the Total Joint-
PSH pathway, and suggest that implementation of a PSH
model of care could help institutions to better control
process costs and identify unwarranted costs. In the case
of the Total Joint-PSH, we have identified an opportun-
ity to decrease variation in the cost of implants and the
cost of PACU time.
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